244 related articles for article (PubMed ID: 15771921)
21. Effect of levosimendan on ventricular arrhythmias and prognostic autonomic indexes in patients with decompensated advanced heart failure secondary to ischemic or dilated cardiomyopathy.
Flevari P; Parissis JT; Leftheriotis D; Panou F; Kourea K; Kremastinos DT
Am J Cardiol; 2006 Dec; 98(12):1641-5. PubMed ID: 17145226
[TBL] [Abstract][Full Text] [Related]
22. Correlation of B type natriuretic peptides with clinical and echocardiographic parameters in heterogeneous population of patients with symptoms suggestive of heart failure.
Piechota WN; Piechota WT; Bejm J; Wierzbowski R; Michałkiewicz D
Adv Med Sci; 2006; 51():164-7. PubMed ID: 17357300
[TBL] [Abstract][Full Text] [Related]
23. Early assessment of outcome in cardiogenic shock: relevance of plasma N-terminal pro-B-type natriuretic peptide and interleukin-6 levels.
Jarai R; Fellner B; Haoula D; Jordanova N; Heinz G; Karth GD; Huber K; Geppert A
Crit Care Med; 2009 Jun; 37(6):1837-44. PubMed ID: 19384228
[TBL] [Abstract][Full Text] [Related]
24. Preoperative treatment with levosimendan in candidates for mechanical circulatory support.
Sponga S; Ivanitskaia E; Potapov E; Krabatsch T; Hetzer R; Lehmkuhl H
ASAIO J; 2012; 58(1):6-11. PubMed ID: 22157071
[TBL] [Abstract][Full Text] [Related]
25. Lowered B-type natriuretic peptide in response to levosimendan or dobutamine treatment is associated with improved survival in patients with severe acutely decompensated heart failure.
Cohen-Solal A; Logeart D; Huang B; Cai D; Nieminen MS; Mebazaa A
J Am Coll Cardiol; 2009 Jun; 53(25):2343-8. PubMed ID: 19539144
[TBL] [Abstract][Full Text] [Related]
26. A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study.
Kazanegra R; Cheng V; Garcia A; Krishnaswamy P; Gardetto N; Clopton P; Maisel A
J Card Fail; 2001 Mar; 7(1):21-9. PubMed ID: 11264546
[TBL] [Abstract][Full Text] [Related]
27. N-terminal pro-B-type natriuretic peptide as an indicator of disease severity in a heterogeneous group of patients with chronic precapillary pulmonary hypertension.
Andreassen AK; Wergeland R; Simonsen S; Geiran O; Guevara C; Ueland T
Am J Cardiol; 2006 Aug; 98(4):525-9. PubMed ID: 16893710
[TBL] [Abstract][Full Text] [Related]
28. Hemodynamic improvement of acutely decompensated heart failure patients is associated with decreasing levels of NT-proBNP.
Knebel F; Schimke I; Diaz Ramirez I; Schattke S; Eddicks S; Borges AC; Baumann G
Int J Cardiol; 2009 May; 134(2):260-3. PubMed ID: 18384896
[TBL] [Abstract][Full Text] [Related]
29. Blood volume and brain natriuretic peptide in congestive heart failure: a pilot study.
James KB; Troughton RW; Feldschuh J; Soltis D; Thomas D; Fouad-Tarazi F
Am Heart J; 2005 Nov; 150(5):984. PubMed ID: 16290978
[TBL] [Abstract][Full Text] [Related]
30. NT-proBNP levels and resting hemodynamic parameters assessed by bioimpedance in patients with chronic heart failure.
Feliciano J; Soares R; Silva S; Fiarresga A; Fernandes RM; Miranda F; Ferreira RC
Rev Port Cardiol; 2007 Oct; 26(10):1021-8. PubMed ID: 18232624
[TBL] [Abstract][Full Text] [Related]
31. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study.
Anwaruddin S; Lloyd-Jones DM; Baggish A; Chen A; Krauser D; Tung R; Chae C; Januzzi JL
J Am Coll Cardiol; 2006 Jan; 47(1):91-7. PubMed ID: 16386670
[TBL] [Abstract][Full Text] [Related]
32. Repeated infusions of levosimendan: well tolerated and improves functional capacity in decompensated heart failure - a single-centre experience.
Parle NM; Thomas MD; Dembo L; Best M; Driscoll GO
Heart Lung Circ; 2008 Jun; 17(3):206-10. PubMed ID: 18242130
[TBL] [Abstract][Full Text] [Related]
33. Transpulmonary B-type natriuretic peptide uptake and cyclic guanosine monophosphate release in heart failure and pulmonary hypertension: the effects of sildenafil.
Melenovsky V; Al-Hiti H; Kazdova L; Jabor A; Syrovatka P; Malek I; Kettner J; Kautzner J
J Am Coll Cardiol; 2009 Aug; 54(7):595-600. PubMed ID: 19660688
[TBL] [Abstract][Full Text] [Related]
34. N-terminal pro-brain natriuretic peptide (NT-proBNP) in healthy blood donors and in patients from general practitioners with and without a diagnosis of cardiac disease.
Hess G; Runkel S; Zdunek D; Hitzler WE
Clin Lab; 2005; 51(3-4):167-72. PubMed ID: 15819172
[TBL] [Abstract][Full Text] [Related]
35. Cardiac efficiency improvement after slow continuous ultrafiltration is assessed by beat-to-beat minimally invasive monitoring in congestive heart failure patients: a preliminary report.
Giglioli C; Landi D; Gensini GF; Valente S; Cecchi E; Scolletta S; Chiostri M; Romano SM
Blood Purif; 2010; 29(1):44-51. PubMed ID: 19907163
[TBL] [Abstract][Full Text] [Related]
36. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure.
Kistorp C; Faber J; Galatius S; Gustafsson F; Frystyk J; Flyvbjerg A; Hildebrandt P
Circulation; 2005 Sep; 112(12):1756-62. PubMed ID: 16157772
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of noninvasive hemodynamic evaluation of the acute effect of levosimendan in advanced heart failure.
Malfatto G; Della Rosa F; Rella V; Villani A; Branzi G; Blengino S; Giglio A; Facchini M; Parati G
J Cardiovasc Med (Hagerstown); 2014 Apr; 15(4):322-30. PubMed ID: 24699010
[TBL] [Abstract][Full Text] [Related]
38. NT-proBNP in monitoring treatment of patients with congestive heart failure.
Al-Meslmani BM; Fahoum SK; Shamia MG
Clin Lab; 2007; 53(1-2):35-9. PubMed ID: 17323823
[TBL] [Abstract][Full Text] [Related]
39. Natriuretic peptides in patients with atrial fibrillation and advanced chronic heart failure: determinants and prognostic value of (NT-)ANP and (NT-pro)BNP.
Rienstra M; Van Gelder IC; Van den Berg MP; Boomsma F; Van Veldhuisen DJ
Europace; 2006 Jul; 8(7):482-7. PubMed ID: 16798760
[TBL] [Abstract][Full Text] [Related]
40. B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide are depressed in obesity despite higher left ventricular end diastolic pressures.
Taylor JA; Christenson RH; Rao K; Jorge M; Gottlieb SS
Am Heart J; 2006 Dec; 152(6):1071-6. PubMed ID: 17161055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
